2011
DOI: 10.1016/j.jocn.2010.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Flow diverters for treatment of intracranial aneurysms: Current status and ongoing clinical trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
87
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 137 publications
(89 citation statements)
references
References 29 publications
(26 reference statements)
1
87
0
1
Order By: Relevance
“…Each Silk FD, regardless of size, is composed of forty 30-nitinol and eight 50-m platinum microfilaments; with pore sizes of 110 -250 . 7,11 For the successful cases, patients 1-4, the aneurysms were completely occluded by 6 months. For the failed cases 5 and 6, persistent residual aneurysms were observed at 6 months.…”
Section: Patients and Imaging Datamentioning
confidence: 99%
See 2 more Smart Citations
“…Each Silk FD, regardless of size, is composed of forty 30-nitinol and eight 50-m platinum microfilaments; with pore sizes of 110 -250 . 7,11 For the successful cases, patients 1-4, the aneurysms were completely occluded by 6 months. For the failed cases 5 and 6, persistent residual aneurysms were observed at 6 months.…”
Section: Patients and Imaging Datamentioning
confidence: 99%
“…The timeframe for complete occlusion of an aneurysm is unknown, but recent series have documented 6-month occlusion rates of 89.0%-93.3%. 7 Of more concern are reports of delayed parenchymal or subarachnoid hemorrhage following FD treatment. These have been estimated to be up to 1.75% for the Pipeline Embolization Device and 0.8% for Silk.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The primary intent of a flow diversion device (as opposed to a stent) is to optimally alter the flow exchange between the parent artery and the aneurysm so as to promote complete thrombosis of the sac as rapidly as possible while eliciting minimal neointimal hyperplasia. The principal goal of the flow divertor is placement in the parent artery in order to reconstruct the vessel wall [37]. The concept of flow diversion appears promising in challenging lesions, including fusiform and/or giant aneurysms.…”
Section: Fddmentioning
confidence: 99%
“…Interventional cardiovascular catheterization, such as stent and coiling are both of the advances to treat aneurysms [6][7][8], should stay in the body and have some complications, such as the displacement of the stent and the coil fall off from the aneurysm [9,10]. Considering the blood coagulation induced by the heating of radiofrequency ablation (RFA), the mechanism of aneurysm embolization and the advantages of simple operation, small trauma, low cost, faster recovery, high success rate, etc [11][12][13][14][15] , Qiao, et al proposed that RFA may be used to treat aneurysm by combining the mechanism of blood coagulation of RFA and aneurysm embolization [16].…”
Section: Introductionmentioning
confidence: 99%